Concepedia

Archana Bommi‐Reddy

AB

Statistics

Publications

10

Citations

1.6K

H-Index

10

Active since

2008

Affiliations

Constellation Pharmaceuticals (United States)(Current)

Harvard University

Dana-Farber Cancer Institute

Howard Hughes Medical Institute

Piramal (India)

Archana Bommi‐Reddy is an author at Constellation Pharmaceuticals (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2008–2022

10

Publications

10

HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α

Zoltàn Arany, ShiYin Foo, Yanhong Ma et al. · Nature · 2008 · 1K citations · Full text

, , +7

Kinase requirements in human cells: III. Altered kinase requirements in<i>VHL</i>−/− cancer cells detected in a pilot synthetic lethal screen

Archana Bommi‐Reddy, Ingrid Almeciga, J. Scott Sawyer et al. · Proceedings of the National Academy of Sciences · 2008 · 140 citations · Full text

Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase

Qing Zhang, Jinming Gu, Lianjie Li et al. · Cancer Cell · 2009 · 140 citations · Full text

, , +10

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

Andrew R. Conery, Richard C. Centore, Adrianne Neiss et al. · eLife · 2016 · 118 citations · Full text

, , +9

Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor

Jonathan E. Wilson, Gaurav Patel, Chirag Patel et al. · ACS Medicinal Chemistry Letters · 2020 · 74 citations · Full text

Rows per page

1–5 of 10